Asset Management One Co. Ltd. Acquires 1,700 Shares of CME Group Inc. (NASDAQ:CME)

Asset Management One Co. Ltd. lifted its holdings in shares of CME Group Inc. (NASDAQ:CME) by 0.8% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 205,347 shares of the financial services provider’s stock after acquiring an additional 1,700 shares during the quarter. Asset Management One Co. Ltd. owned approximately 0.06% of CME Group worth $45,310,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Salomon & Ludwin LLC bought a new stake in CME Group in the 1st quarter valued at $28,000. Y.D. More Investments Ltd bought a new stake in CME Group in the 2nd quarter valued at $36,000. Thurston Springer Miller Herd & Titak Inc. boosted its stake in CME Group by 62.2% in the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock valued at $43,000 after purchasing an additional 74 shares during the period. McClarren Financial Advisors Inc. boosted its stake in CME Group by 66.1% in the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after purchasing an additional 78 shares during the period. Finally, Asset Dedication LLC boosted its stake in CME Group by 515.2% in the 2nd quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock valued at $40,000 after purchasing an additional 170 shares during the period. 87.75% of the stock is currently owned by institutional investors.

CME Group Trading Up 0.2 %

Shares of NASDAQ CME traded up $0.41 during trading on Monday, reaching $224.02. The company had a trading volume of 11,301 shares, compared to its average volume of 1,908,570. The company’s fifty day moving average price is $220.69 and its 200-day moving average price is $209.49. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $230.36. The stock has a market cap of $80.67 billion, a P/E ratio of 23.51, a PEG ratio of 5.67 and a beta of 0.55. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, beating analysts’ consensus estimates of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The firm had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same quarter in the previous year, the company posted $2.25 EPS. The business’s revenue was up 18.4% on a year-over-year basis. As a group, research analysts expect that CME Group Inc. will post 10.23 earnings per share for the current year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were given a dividend of $1.15 per share. The ex-dividend date was Monday, September 9th. This represents a $4.60 annualized dividend and a dividend yield of 2.05%. CME Group’s payout ratio is 48.37%.

Insider Activity at CME Group

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, CFO Lynne Fitzpatrick sold 754 shares of the stock in a transaction that occurred on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the sale, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at $2,877,504.39. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the sale, the director now directly owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 15,221 shares of company stock worth $3,351,895 in the last 90 days. Corporate insiders own 0.30% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have weighed in on CME shares. Oppenheimer lifted their price objective on CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a report on Thursday, October 24th. JPMorgan Chase & Co. lifted their price objective on CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a report on Thursday, July 25th. Piper Sandler boosted their price target on CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a report on Monday, October 28th. The Goldman Sachs Group boosted their price target on CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a report on Thursday, October 3rd. Finally, Barclays boosted their price target on CME Group from $219.00 to $231.00 and gave the stock an “equal weight” rating in a report on Thursday, October 24th. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $222.73.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.